FDA Variance Approval Letter to Dapper Rave, LLC
Summary
The Food and Drug Administration (FDA) has issued a variance approval letter to Dapper Rave, LLC, through its Center for Devices and Radiological Health (CDRH). This document signifies an approval for a specific variance requested by the company.
What changed
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Dapper Rave, LLC. This document indicates that a specific request for a variance from standard FDA regulations has been granted to the company. The exact nature of the variance and the specific regulations it pertains to are not detailed in the provided metadata, but it represents an official FDA decision on a company's request.
Compliance officers should note that this is a final, approved variance for a specific entity. While this approval is specific to Dapper Rave, LLC, it may set a precedent or provide insight into the FDA's considerations for similar requests from other entities in the future. It is advisable to review the full document if Dapper Rave, LLC operates within your organization's supply chain or if your company intends to seek similar variances.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Variance Approval Letter from FDA CDRH to Dapper Rave, LLC
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.